WC
ALPN

Wexford Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Wexford Capital’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,100
Closed -$916K – 276
2024
Q1 		$916K Buy
+23,100
New +$682K 0.19% 92

Wexford Capital's ALPN Position: Q2 2024 in Review

Wexford Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 23,100 shares — an estimated $916K sold.

Wexford Capital first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $916K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Wexford Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Wexford Capital sold 23,100 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $916K.
  • Wexford Capital first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • Wexford Capital's Alpine Immune Sciences Inc position peaked at $916K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Wexford Capital's 13F filing for Q2 2024, filed 14 Aug 2024.